Effects of Aromatherapy in Patients with Leukemia: Impact of Gender, Age, and Scent Preference by Honebrink, Erin
Running	  Head:	  AROMATHERAPY	  EFFECTS	  ON	  GENDER,	  AGE,	  AND	  SCENT	   1	  



























Honors Thesis Committee 
 




AROMATHERAPY	  EFFECTS	  ON	  GENDER,	  AGE,	  AND	  SCENT	   	  	   2	  
Abstract 
Patients newly diagnosed with acute leukemia experience an array of different 
symptoms throughout their chemotherapy treatments in the hospital. Aromatherapy, the 
use of essential oils through diffusion, is often used to alleviate some of these symptoms. 
The purpose of this study was to: (1) to examine the difference in response to 
aromatherapy in patients with acute leukemia by gender on sleep quality and other 
common symptoms associated with cancer; (2) to examine the difference in response to 
aromatherapy in patients with acute leukemia by age on sleep quality and other common 
symptoms associated with cancer; (3) to determine if there is a difference in response to 
aromatherapy among patients with leukemia by scent selection. This randomized, cross-
over, wash out trial included fifty acute leukemia patients in the hospital for their initial 
chemotherapy treatments. These patients were all at least eighteen years of age and were 
offered a choice between three different scents of aromatherapy: lavender, peppermint, or 
chamomile. Patients were randomized to receive either aromatherapy or placebo during 
week one. During the second week (washout period), nothing was diffused, and during 
the third week the opposite intervention was given. Major outcome variables include 
sleep quality measured by the Pittsburgh Sleep Quality Index and other common cancer 
side effect symptoms measured by the Edmonton Symptoms Assessment Scale. Patients 
completed a Final Evaluation of Aromatherapy to evaluate their experience with the 
aromatherapy. Our results showed us that aromatherapy as a whole had a positive impact 
on patient experience and managed symptoms well. There was no statistically significant 
difference between males and females or by age. The lavender scent was most commonly 
chosen. Overall, aromatherapy has decreased the common symptoms associated with 
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Chapter 1 
Introduction 
The term “aromatherapy” refers to the use of essential oils that come from plants with the 
intent to calm, relax, and strengthen a person’s spirit (Louis, 2002). The use of 
aromatherapy has been around for many years, however it is just recently becoming more 
popular among nurses and other healthcare providers The purpose of the primary study 
was to determine if aromatherapy improved insomnia and other common symptoms in 
newly diagnosed hospitalized	  leukemia	  patients,	  including	  pain,	  nausea,	  lack	  of	  appetite,	  shortness	  of	  breath,	  depression,	  anxiety	  and	  wellbeing	  and	  if	  patients	  perceive	  aromatherapy	  as	  a	  positive	  experience	  for	  symptom	  management.	  	  This	  study	  was	  a	  secondary	  analysis.	  	  The	  aims	  of	  this	  study	  were	  to:	  1) to examine the 
difference in response to aromatherapy in patients with acute leukemia by gender on 
sleep quality and other common symptoms associated with cancer; (2) to examine the 
difference in response to aromatherapy in patients with acute leukemia by age on sleep 
quality and other common symptoms associated with cancer; (3) to determine if there is a 
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Chapter II 
 
Review of Literature 
 
Signs and Symptoms of Leukemia 
 Leukemia is a progressive form of cancer in which a person’s bone marrow 
produces increased numbers of immature or abnormal leukocytes (Danyi, 2016). This 
disease can take many forms and presents in a variety of different clinical signs and 
symptoms. Some of these underlying issues at the cellular level include, but are not 
limited to, low levels of hemoglobin, a low platelet count, a low neutrophil count, poor 
effects of non-steroidal anti-inflammatory drug therapy, enlarged spleen, and increased 
levels of monocytes (Danyi, 2016).  
 While those changes are occurring within the body, many changes outside the 
body are beginning to develop as well as a result. The low hemoglobin could lead to 
signs and symptoms of anemia, while the low platelet count causes the patient to become 
extremely immunosuppressed. While in an immunocompromised status, the patient is 
more susceptible to infection and other disease processes that intensify the existing 
problems. Because of this, the treatment for this type of cancer typically includes 
chemotherapy. 
Signs and Symptoms of Chemotherapy 
Chemotherapy is the most common form of cancer treatment that uses drugs to 
destroy the numerous and multiplying cancer cells. Many people are intimidated by the 
idea of chemotherapy because of the devastating symptoms associated with it such as hair 
loss, nausea and vomiting, and constipation or diarrhea. Chemotherapy targets a certain 
type of cell that also exists in areas around the mouth or hair, thus leading to hair loss. 
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Because these symptoms can be treated by other medications and due to the previous 
successes in the past, chemotherapy is the most widely used and most successful form of 
treatment for treating most types of cancers. There have been various studies on the 
effects of aromatherapy on managing symptoms related to chemotherapy. Some have 
proven beneficial to managing symptoms well, while others conclude that there is not 
substantial evidence to say one way or the other (Lua).  
Aromatherapy In Other Patient Groups 
 Aromatherapy is widely used among many people for a variety of reasons, and 
one of the biggest and most common reasons for the use of aromatherapy is to treat 
insomnia. Insomnia is defined as the subjective dissatisfaction with the duration or 
quality of sleep (Lewith, 2005). While getting enough sleep is important for a person’s 
health and well being, a lack of sleep can actually cause fatigue, drowsiness, nervousness, 
dizziness, instability, disorientation, and attention disorders (Hwang, 2015). Because 
aromatherapy is one of the most rapidly growing areas of complementary medicine, 
victims of insomnia are typically most interested in trying this method as a way to cure 
their sleep disorder. Different studies have reviewed the effects of aromatherapy and 
determined that it has decreased many of the patients’ psychological factors, including 
depression, anxiety, and stress, while also having a positive effect on factors such as 
sleep and relieving pain (Hwang, 2015). 
 Aromatherapy is also widely used with the hospice and end of life population. 
One of the most important goals in palliative care is achieving a good death or a good 
dying process in the last stages of life (Nakano, 2013). Unfortunately, many of these 
patients in hospice are in need of additional interventions that promote this sense of 
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comfort. Because of the lower price, lack of negative side effects, and ease of 
administration, aromatherapy is one of the most widely chosen supplements (Louis, 
2002). One of the biggest problems with patients in hospice is the feeling of depression. 
When an individual suffers from depression, the symptoms include loss of interest, loss 
of energy, weight gain, insomnia, depressed mood, difficulties in thinking and 
concentrating, and recurrent thoughts of death (Yim, 2009). Again, because of the 
symptoms that these people present with, aromatherapy seems to be the front-runner in 
adjunctive medicine.  
Current Research in Aromatherapy  
          Aromatherapy is a type of therapy in which the outcome is difficult to interpret. It 
typically includes evaluations of subjective data by judging how a patient is physically 
and mentally feeling after the treatment is completed. Because of this, aromatherapy is 
still in its infancy and requires much more research to be performed on its behalf. 
However, even though much more information is needed on this subject as a whole, we 
have been able to get a good understanding as to how aromatherapy works and what the 
typical outcomes should look like.  
Two of the most commonly researched methods of using aromatherapy include 
massages and aromasticks. The main aim of using aromatherapy massage in cancer care 
is to improve patients’ quality of life and reduce psychological distress (Fellowes, 2004). 
Some studies have shown that cortisol levels have decreased after aromatherapy and 
massage and may have had a positive impact on patients dealing with a life-threatening 
illness (Stringer, J., Swindell, R., 2008). The literature states that when the participants 
listed some of the benefits they experienced after going through a treatment of 
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aromatherapy massage, they included feelings of relaxation, increased energy levels, 
better sleeping patterns, and a reduction in tension (Dunwoody, 2002). These can all lead 
to a person gaining their strength back and easing some of their discomfort during this 
time. 
An aromastick is defined as “an individual plastic inhaler device containing an 
inner wick which is blank permitting the addition of essential oils” (Dyer, 2014). This is 
an example of another popular way that aromatherapy is administered to patients. The 
scent of the aromasticks can play a very important role in the outcomes of these patients’ 
treatment. The odor from the oils can actually stimulate memory or emotion in the brain 
and have some physical effects as well (Stringer, J., Donald, G., 2011). This is becoming 
a more commonly used device because of the ease of carrying around a portable device 
along with the positive effects that patients have reported with this treatment. 
Conclusion  
 Despite the lack of research on aromatherapy there is still enough research 
presented to be able make an overall conclusion about this intervention: it has improved 
the quality of life and relieved symptoms of patients with cancer, while not causing any 
negative outcomes. This is a very important discovery in the medical field because of the 
high prevalence of cancer in today’s society. While most literature to this day talks about 
the effects of aromatherapy as a whole, little is known about the effects on leukemia 
patients specifically. This study is meant to address this gap and determine the outcomes 
of using this form of treatment. Patients with cancer almost always go through the 
chemotherapy process and struggle through its many side effects and consequences. 
Aromatherapy has been shown to work for these patients a countless number of times and 
AROMATHERAPY	  EFFECTS	  ON	  GENDER,	  AGE,	  AND	  SCENT	   	  	   9	  












































 A secondary analysis of a randomized, cross-over, wash out trial, with the 
experimental group acting as its own control. This was a three-week trial with 
participants randomly assigned to either the placebo or aromatherapy treatment during 
the first week. The second week consists of a washout period, followed by either the 
placebo or the aromatherapy during the third week. Patients were chosen randomly using 
a computer-generated table of random numbers. 
Setting 
 This study took place on the acute leukemia unit at the James Cancer Hospital at 
the Ohio State University Wexner Medical Center. The James Cancer Hospital has 
received high rankings from the National Cancer Institute and is consistently voted as one 
of the top cancer hospitals in the nation. With 962 beds, it is the largest cancer hospital in 
the Midwest and third largest in the country. 
Sample 
 This study included fifty patients of eighteen years or older that were hospitalized 
on an acute leukemia unit. Inclusion criteria included that these patients were newly 
diagnosed and hospitalized to receive four weeks of intensive induction chemotherapy. 
Exclusion criteria included a history of asthma, sleep apnea, a planned less than three 
week hospitalization, patients who had not completed their initial steroids, patients who 
were confused and unable to give informed consent, non-English speaking patients, and 
patients with previous experience with aromatherapy. 
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Instrument 
 The Pittsburgh Sleep Quality Index (PSQI) is a questionnaire that assesses sleep 
quality and any disturbances over a certain time frame. The “component” scores in this 
study include subjective sleep quality, sleep latency, sleep duration, habitual sleep 
efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. The 
sum of these scores for these components results in one overall score. The overall score 
ranges from 0 (best sleep) to 21 (worst sleep). PSQI	  has	  six	  subscales.	  	  Subjects	  are	  asked	  to	  rank	  each	  subscale	  by	  using	  a	  Likert	  scale,	  which	  ranges	  from	  0-­‐3.	  	  These	  subscales	  include	  Duration	  of	  Sleep,	  Sleep	  Latency	  (the	  time	  it	  takes	  a	  person	  to	  fall	  asleep),	  Day	  Dysfunction	  Due	  To	  Sleepiness,	  Sleep	  Efficiency	  (the	  ratio	  of	  time	  spent	  in	  bed	  to	  time	  spent	  being	  asleep),	  Overall	  Sleep	  Quality,	  and	  Needs	  Medications	  to	  Sleep.	  The	  scale	  ranges	  from	  0	  (best	  sleep)	  to	  21	  (worst	  sleep).	  A	  score	  of	  3	  would	  be	  the	  highest	  and	  worst	  sleep	  among	  each	  individual	  subcategory.	  	  A	  total	  overall	  score	  of	  >5	  indicates	  the	  person	  has	  poor	  sleep	  quality.	  A study on the reliability and 
validity of the PSQI concluded that this index has high test-retest reliability for patients 
with primary insomnia. The seven component scores of the PSQI had an overall 
reliability coefficient of 0.83, indicating a high degree of internal consistency. The 
correlation of PSQI data with sleep logs during the study demonstrates good validity of 
the PSQI. The article reminds us to keep in mind that the PSQI score alone does not 
allow for differentiation of the different sleep disorders due to psychiatric disorders, so 
the validity of some of the questions should be evaluated further. Overall, research has 
concluded that the PSQI proved valuable to clinical work on insomnia and is a useful 
first-line and easy-to-handle questionnaire to evaluate sleep disturbance (Backhaus, 
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2002). This index will be completed before the experiment begins to gather a baseline for 
insomnia. It will then be given at the end of week 1 (Day 8) in the morning, at the end of 
week 2 (Day 15) in the morning, and at the end of week 3 (Day 22) in the morning. 
 The Edmonton Symptom Assessment Scale (ESASr) is an 11-point numerical 
rating scale for self-report of nine common symptoms of cancer. The ESASr uses a visual 
analogue scale with a range of 0-10, with the number 0 indicating an absence of the 
symptom and the number 10 being the worst possible symptom. A recent study on the 
reliability and validity of the ESASr has concluded that this newer version of the original 
ESAS has been vastly improved and more easily understood among patients. While more 
research needs to be conducted, the findings of this study support the use of the ESASr 
for use in symptom screening (Watanabe, 2012). This scale will be first completed prior 
to the experiment to gather a baseline. It will then be completed every morning by the 
patient throughout the remainder of the experiment. 
 The Final Evaluation of Aromatherapy (FEA) had the patient rate their general 
experience with aromatherapy on a scale from 1-10, with 1 being terrible and 10 being 
exceptional. The tool also asked the patient for any positive or negative comments 
regarding the use of aromatherapy. This is an investigator-developed tool in which 
patients rate their general experiences. It will also ask the patient which week, week one 
or three, they believe they received the aromatherapy. It was completed at the end of 
week 1 (Day 8) in the morning and at the end of week 3 (Day 22) in the morning. 
Data Collection Procedures 
 After obtaining approval by the Cancer Scientific Research Committee and 
Institutional Review Board, the potential patients were screened by the leukemia clinical 
AROMATHERAPY	  EFFECTS	  ON	  GENDER,	  AGE,	  AND	  SCENT	   	  	   13	  
nurse specialist and the multidisciplinary team for inclusion and exclusion criteria. The 
patients who met criteria were then approached for informed consent. Because of the 
importance of scents, the patients were given the choice between three different scents of 
essential oils: lavender, peppermint, or chamomile. Patients were first introduced to the 
smell by placing a drop of the oil on a cotton pad for them to smell. They were provided 
with coffee beans to smell in between scents. Rose water was used as the placebo, as it 
does not have a scent and is not an essential oil. A diffuser with either the essential oil or 
the placebo was placed in a predetermined, measured spot within the patient room to 
ensure the diffusion of the oils was consistent with each patient. Neither the patient nor 
the researchers were aware if the oils were aromatherapy or placebo. Standard 
aromatherapy bottles were used for both the essential oils and the placebo, and all bottles 
were obscured with tape. Diffusion of the oils began around 9PM rounds and continued 
until the solution ran dry, about eight hours later. Patient doors were kept closed during 
the diffusion unless staff needed to enter or exit the room. The PSQI, ESASr, and FEA 
were then used to determine the effects of the essential oils on patients regarding 
insomnia, symptoms, and feelings toward aromatherapy. 
Data Analysis 
 Data was analyzed using SPSS version 21.0. Descriptive statistics were used to 
evaluate the characteristics of the sample include gender, age, and scent selection on the 
PSQI and, ESASr..  T T-tests were then used to determine difference in PQSI, ESASr by 
gender on the scores for the week in which aromatherapy was given (either week 1 or 
week 3).  One-way ANOVA tests were used to determine difference in PQSI, ESASr by 
age category and scent selection. 
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Chapter	  V	  
	  
Results	  	  	   A	   total	   of	   50	   subjects	   newly	   diagnosed	   patients	  with	   acute	   leukemia	  were	  enrolled	  in	  this	  study.	  The	  ages	  ranged	  from	  19-­‐72	  years	  with	  50%	  of	  the	  subjects	  between	  the	  ages	  of	  41-­‐60,	  and	  56%	  of	  the	  subjects	  were	  male	  (Table	  1).	  Out	  of	  the	  three	   options	   for	   aromatherapy	   scents,	   lavender	   was	   most	   commonly	   chosen	   by	  58%	  of	  the	  people,	  followed	  by	  peppermint	  and	  chamomile.	  	  
Aim	  1	  To examine the differences in response to aromatherapy in patients with 
acute leukemia by gender on sleep quality and other common symptoms associated with 
cancer	   Table	  2	  shows	  us	  a	  T-­‐Test	  of	  the	  difference	  between	  males	  and	  females	  using	  the	  PSQI.	  Females’	  total	  sleep	  score	  (X=9.09)	  was	  lower	  than	  males’	  (X=10.18),	  indicating	  that	  they	  had	  reported	  slightly	  better	  sleep	  quality,	  although	  the	  difference	  was	  not	  statistically	  significant	  (p=.29).	  Within	  the	  subscales,	  subjects	  were	  least	  disturbed	  by	  Day	  Dysfunction	  Due	  To	  Sleepiness	  (X=.50	  and	  X=.46).	  Both	  male	  (X=2.91)	  and	  female	  subjects	  (X=2.89)	  had	  the	  most	  difficulties	  with	  Sleep	  Efficiency	  (p=.84)	  	  Overall,	  there	  were	  no	  statistically	  significant	  differences	  in	  the	  subscales	  of	  the	  PSQI	  between	  males	  and	  females.	  Tables	  3	  and	  4	  show	  the	  descriptive	  data	  and	  T-­‐test	  results	  for	  the	  difference	  between	  genders	  using	  the	  ESASr.	  	  The	  mean	  score	  for	  all	  patients	  in	  regards	  to	  symptoms	  on	  the	  ESASr	  was	  21.05.	  	  There	  is	  no	  statistically	  significant	  difference	  between	  males	  and	  females	  when	  looking	  at	  the	  various	  common	  symptoms	  as	  measured	  by	  the	  ESARr.	  	  Both	  genders	  responded	  similarly	  in	  each	  category.	  On	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  males	  and	  females	  reported	  that	  the	  aromatherapy	  helped	  relieve	  their	  shortness	  of	  breath	  most	  effectively	  (1.21)	  and	  their	  tiredness	  least	  effectively	  (3.82)	  compared	  to	  the	  other	  subcategories.	  	  
Aim 2: To	  examine	  the	  difference	  in	  response	  to	  aromatherapy	  in	  patients	  with	  acute	  leukemia	  by	  age	  on	  sleep	  quality	  and	  other	  common	  symptoms	  associated	  with	  cancer.	  Table	  5	  shows	  us	  the	  breakdown	  of	  the	  different	  age	  groups,	  number	  of	  members	  in	  each	  group,	  and	  their	  average	  score	  on	  each	  subcategory	  of	  the	  PSQI.	  Out	  of	  each	  age	  group,	  the	  table	  shows	  that	  the	  sleep	  quality	  actually	  slightly	  increased	  with	  age.	  The	  mean	  total	  score	  for	  19-­‐40	  year	  olds	  is	  10.30	  while	  the	  61-­‐72	  year	  old	  group	  averaged	  9.19	  on	  the	  scale,	  being	  the	  best	  sleep	  out	  of	  the	  four	  groups.	  After	  completing	  the	  ANOVA	  test	  on	  this	  data	  (Table	  6),	  we	  see	  that	  despite	  the	  slight	  differences	  in	  PSQI	  results,	  there	  is	  no	  significant	  difference	  in	  the	  response	  of	  the	  subjects	  by	  age	  category	  with	  respect	  to	  each	  of	  these	  difference	  subscales	  (p=.88).When	  looking	  at	  the	  difference	  between	  age	  groups	  in	  the	  ESASr,	  Table	  7	  and	  Table	  8	  show	  us	  the	  descriptive	  data	  and	  ANOVA	  test	  that	  was	  performed	  on	  the	  data.	  Unlike	  the	  PSQI	  results,	  the	  19-­‐40	  year	  old	  group	  actually	  showed	  that	  the	  aromatherapy	  slightly	  helped	  alleviate	  symptoms	  better	  than	  any	  other	  age	  group	  (18.59),	  while	  the	  61-­‐72	  year	  old	  age	  group	  reported	  a	  21.21	  out	  of	  100.	  However,	  the	  data	  do	  not	  show	  any	  statistically	  significant	  difference	  between	  the	  different	  age	  groups	  in	  regards	  to	  the	  various	  subcategories.	  The	  tiredness	  category	  remains	  the	  category	  in	  which	  most	  people	  report	  the	  aromatherapy	  did	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  not	  benefit	  them	  as	  much	  (3.79),	  while	  it	  seemed	  to	  help	  alleviate	  shortness	  of	  breath	  (1.22)	  and	  depression	  (1.24)	  most	  effectively.	  	  	  	  	  	  Aim	  3:	  To	  determine	  if	  there	  are	  differences	  in	  responses	  to	  aromatherapy	  among	  acute	  leukemia	  by	  scent	  selection.	  Table	  9	  shows	  how	  many	  times	  each	  of	  the	  scents	  have	  been	  chosen	  by	  patients	  and	  the	  mean	  score	  it	  received	  on	  the	  PSQI	  for	  each	  subcategory.	  Out	  of	  the	  three	  scents	  (lavender,	  peppermint,	  and	  chamomile),	  lavender	  was	  most	  commonly	  chosen	  with	  29	  people	  followed	  by	  peppermint	  and	  finally	  chamomile.	  After	  examining	  the	  descriptive	  date	  for	  all	  of	  the	  scents,	  chamomile	  reported	  the	  lowest	  score	  on	  the	  PSQI	  with	  a	  mean	  score	  of	  7.57,	  indicating	  it	  resulted	  in	  the	  best	  sleep	  quality,	  while	  lavender	  had	  a	  mean	  score	  of	  9.72	  and	  peppermint	  had	  a	  mean	  score	  of	  10.71.	  Again,	  in	  this	  table	  it	  shows	  that	  the	  subcategory	  Day	  Dysfunction	  due	  to	  Sleepiness	  had	  the	  lowest	  reported	  scores	  among	  the	  other	  subcategories	  with	  0.48,	  indicating	  that	  all	  of	  the	  scents	  seemed	  to	  have	  some	  positive	  impact	  on	  their	  daytime	  function.	  After	  running	  the	  ANOVA	  test	  on	  this	  data,	  the	  Day	  Dysfunction	  due	  to	  Sleepiness	  was	  the	  only	  subcategory	  that	  was	  statistically	  significant	  with	  a	  significance	  of	  0.039	  (Table	  10).	  This	  shows	  that	  there	  is	  a	  significant	  difference	  when	  comparing	  the	  difference	  between	  all	  three	  of	  the	  scents	  individually.	  Table	  11	  shows	  the	  descriptive	  information	  about	  the	  three	  different	  scents	  and	  the	  mean	  score	  they	  received	  after	  patients	  took	  the	  ESASr.	  After	  comparing	  the	  results,	  the	  lavender	  reported	  the	  lowest	  mean	  score	  of	  19.33,	  indicating	  it	  helped	  alleviate	  the	  symptoms	  the	  best	  overall,	  while	  peppermint	  had	  the	  lowest	  mean	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  score	  on	  average	  at	  23.00.	  Tiredness,	  again,	  ranked	  the	  lowest	  among	  the	  other	  subcategories	  with	  a	  score	  of	  3.79.	  Coincidently,	  the	  subcategory	  Shortness	  of	  Breath	  reported	  a	  1.22,	  and	  Depression	  reported	  a	  1.24	  like	  the	  PSQI	  results	  as	  well,	  implying	  that	  the	  aromatherapy	  again	  had	  the	  most	  beneficial	  impact	  on	  these	  categories.	  Another	  thing	  to	  note	  is	  the	  peppermint	  result	  in	  the	  Wellbeing	  subcategory.	  It	  reported	  as	  a	  3.62,	  while	  the	  average	  was	  almost	  an	  entire	  point	  lower	  at	  2.64.	  This	  shows	  that	  peppermint	  definitely	  did	  not	  benefit	  the	  patient	  in	  this	  category,	  and	  may	  have	  even	  made	  the	  patient’s	  wellbeing	  worse	  during	  this	  time	  because	  of	  the	  significant	  difference	  between	  results.	  After	  running	  the	  ANOVA	  test	  on	  the	  data,	  the	  Wellbeing	  category	  was	  the	  only	  one	  that	  was	  statistically	  significant	  with	  a	  significance	  of	  0.027	  (Table	  12).	  This	  shows	  that	  the	  lavender	  scent	  had	  a	  more	  favorable	  impact	  than	  the	  other	  scents.	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Chapter V 
Discussion and Conclusion 	  	  	  	  	  	  	  	  	  The	  goal	  of	  the	  primary	  study	  was	  to	  determine	  the	  effects	  that	  aromatherapy	  had	  on	  a	  leukemia	  patient’s	  sleep	  quality,	  symptom	  management,	  and	  overall	  wellbeing.	  	  After	  that	  initial	  experiment	  concluded,	  it	  is	  determined	  that	  the	  aromatherapy	  had	  a	  positive	  impact	  on	  patients	  undergoing	  chemotherapy	  in	  the	  hospital	  setting	  which	  adds	  to	  the	  growing	  body	  of	  evidence	  suggesting	  that	  aromatherapy	  is	  beneficial	  to	  hospitalized	  patients.	  This	  study,	  specifically,	  looked	  at	  the	  effects	  it	  had	  on	  gender,	  age,	  and	  scent	  preference.	  The	  results	  in	  Chapter	  IV	  suggest	  that	  there	  really	  is	  no	  statistical	  significance	  in	  regards	  to	  the	  difference	  in	  gender	  or	  age	  group.	  The	  lack	  of	  significant	  difference	  between	  the	  genders	  and	  age	  groups	  suggest	  that	  the	  aromatherapy	  benefits	  all	  subjects	  irrespective	  of	  gender	  or	  age.	  This	  is	  consistent	  with	  previous	  studies	  that	  have	  reported	  that	  aromatherapy	  interventions	  do	  not	  cause	  harm	  when	  recipients	  are	  screened	  properly	  (Hines,	  Steels,	  Chang	  &	  Gibbons,	  2012;	  Hodge,	  McCarthy	  &	  Pierce,	  2014;	  Varney	  &	  Buckle,	  2013).	  	  	  	  These	  results	  are	  encouraging	  and	  provide	  nurses	  and	  other	  with	  the	  opportunity	  to	  consider	  and	  explore	  the	  use	  of	  complimentary	  alternative	  therapies	  in	  their	  repertoire	  of	  comfort	  measures.	  Nurses	  can	  initiate	  aromatherapy	  without	  a	  medical	  order	  and	  it	  requires	  minimal	  training.	  	  This	  offers	  both	  nurses	  and	  patients	  the	  opportunity	  to	  consider	  non-­‐pharmaceutical	  approaches	  for	  some	  of	  these	  symptoms.	  Additionally,	  nurses	  can	  teach	  oncology	  patients	  to	  use	  aromatherapy	  post-­‐discharge.	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Table	  1:	  
Subject	  Demographic	  Information	  Results	  	  
Sex	  (m=male,	  f=female)	  	   Frequency	   Percent	   Valid	  Percent	   Cumulative	  Percent	   	  F	   22	   44.0	   44.0	   44.0	   	  M	   28	   56.0	   56.0	   100.0	   	  Total	   50	   100.0	   100.0	   	   	  	   	   	   	   	   	  
Chosen	  Scent	  	   Frequency	   Percent	   Valid	  Percent	   Cumulative	  Percent	   	  Chamomile	   7	   14.0	   14.0	   14.0	   	  Lavender	   29	   58.0	   58.0	   72.0	   	  Peppermint	   14	   28.0	   28.0	   100.0	   	  Total	   50	   100.0	   100.0	   	   	  	   	   	   	   	   	  
Descriptive	  Statistics	  	   N	   Minimum	   Maximum	   Mean	   Standard	  Deviation	  Age	   50	   19	   72	   51.70	   13.453	  Valid	  N	  (listwise)	   50	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Table	  2:	  
PSQI	  and	  Gender	  
	   	  







(2-­‐tailed)	  Duration	  of	  Sleep	   F	   1.09	   .650	   48	   .312	  M	   1.43	  Sleep	  Latency	   F	   .95	   .816	   48	   .388	  M	   1.18	  Day	  Dysfunction	  Due	  To	  Sleepiness	   F	   .50	   .799	   48	   .841	  M	   .46	  Sleep	  Efficiency	   F	   2.91	   .813	   48	   .893	  M	   2.89	  Overall	  Sleep	  Quality	   F	   1.23	   .926	   47	   .229	  M	   1.52	  Need	  Meds	  To	  Sleep	   F	   1.09	   .358	   47	   .636	  M	   1.26	  Total	   F	   9.09	   .270	   48	   .294	  M	   10.18	  	  
Table	  3:	  
ESASr	  and	  Gender	  Descriptives	  	   	   Gender	   N	   Mean	   Standard	  Deviation	  Total	   F	  M	   21	  27	   21.99	  20.11	   10.717	  12.511	  Pain	   F	  M	   21	  27	   2.22	  2.63	   1.692	  2.353	  Tiredness	   F	  M	   21	  27	   4.06	  3.58	   1.439	  1.958	  Drowsiness	   F	  M	   21	  27	   3.31	  2.73	   1.707	  1.939	  Nausea	  	   F	  M	   21	  27	   1.83	  1.47	   2.259	  1.670	  Lack	  of	  Appetite	   F	  M	   21	  27	   3.82	  3.56	   2.582	  2.676	  Shortness	  of	  Breath	   F	  M	   21	  27	   1.18	  1.24	   1.551	  1.679	  Depression	  	   F	  M	   21	  27	   1.24	  1.24	   1.568	  1.693	  Anxiety	   F	  M	   21	  27	   1.46	  1.49	   1.464	  1.976	  Wellbeing	   F	  M	   21	  27	   2.72	  2.58	   1.591	  1.985	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Table	  4:	  
ESASr	  and	  Gender	   	  	  
	   Levene’s	  Test	  for	  
Equality	  of	  Variances	   T-­‐Test	  for	  Equality	  of	  Means	  




Difference	  Total	   .901	   .347	   .550	   46	   .585	   1.882	  Pain	   2.118	   .152	   -­‐.661	   46	   .512	   -­‐.402	  Tiredness	   3.184	   .081	   .947	   46	   .348	   .483	  Drowsiness	   2.465	   .123	   1.083	   46	   .284	   .580	  Nausea	   1.418	   .240	   .633	   46	   .530	   .359	  Lack	  of	  Appetite	   .094	   .761	   .339	   46	   .736	   .260	  Shortness	  of	  Breath	   .464	   .499	   -­‐.127	   46	   .900	   -­‐.060	  Depression	   .002	   .963	   .008	   46	   .994	   .004	  Anxiety	   .798	   .376	   -­‐.045	   46	   .965	   -­‐.023	  Wellbeing	   2.813	   .100	   .276	   46	   .784	   .147	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Table	  5:	  
PSQI	  and	  Age	  Descriptives	  	   	  	   N	   Mean	   Standard	  Deviation	  Duration	  of	  Sleep	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  19-­‐40	  41-­‐50	  51-­‐60	  61-­‐72	  Total	  
10	  12	  12	  16	  50	  
1.30	  1.25	  1.25	  1.31	  1.28	  
1.25	  1.22	  1.14	  1.20	  1.16	  Sleep	  Latency	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  19-­‐40	  41-­‐50	  51-­‐60	  61-­‐72	  Total	  
10	  12	  12	  16	  50	  
1.30	  1.17	  1.00	  .94	  1.08	  
1.25	  .84	  .74	  .85	  .90	  Day	  Dysfunction	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  19-­‐40	  Due	  To	  Sleepiness	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  41-­‐50	  51-­‐60	  61-­‐72	  Total	  
10	  12	  12	  16	  50	  
.60	  .58	  .58	  .25	  .48	  
.52	  .67	  .67	  .58	  .61	  Sleep	  Efficiency	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  19-­‐40	  41-­‐50	  51-­‐60	  61-­‐72	  Total	  
10	  12	  12	  16	  50	  
3.00	  2.83	  2.75	  3.00	  2.90	  
.00	  .58	  .62	  .00	  .42	  Overall	  Sleep	  Quality	  	  	  	  	  	  	  	  	  	  19-­‐40	  41-­‐50	  51-­‐60	  61-­‐72	  Total	  
10	  12	  11	  16	  49	  
1.30	  1.67	  1.36	  1.25	  1.39	  
.82	  .99	  .81	  .78	  .84	  Need	  Meds	  To	  Sleep	  	  	  	  	  	  	  	  	  	  	  19-­‐40	  41-­‐50	  51-­‐60	  61-­‐72	  Total	  
10	  12	  11	  16	  49	  
1.50	  1.08	  1.09	  1.13	  1.18	  
1.18	  1.24	  1.14	  1.36	  1.22	  Total	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  19-­‐40	  41-­‐50	  51-­‐60	  61-­‐72	  Total	  
10	  12	  12	  16	  50	  
10.30	  10.00	  9.58	  9.19	  9.70	  
4.24	  3.36	  3.52	  3.69	  3.60	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Table	  6:	  
PSQI	  and	  Age	  	  	   Sum	  of	  Squares	   df	   Mean	  Square	   F	   Sig.	  Duration	  of	  Sleep	   Between	  Groups	   .043	   3	   .014	   .010	   .999	  Within	  Groups	   66.038	   46	   1.436	   	   	  Total	   66.080	   49	   	   	   	  Sleep	  Latency	   Between	  Groups	   .976	   3	   .325	   .387	   .763	  Within	  Groups	   38.704	   46	   .841	   	   	  Total	   39.680	   49	   	   	   	  Day	  Dysfunction	  due	  to	  Sleepiness	  
Between	  Groups	   1.247	   3	   .416	   1.109	   .355	  Within	  Groups	   17.233	   46	   .375	   	   	  Total	   18.480	   49	   	   	   	  
Sleep	  Efficiency	   Between	  Groups	   .583	   3	   .194	   1.130	   .347	  Within	  Groups	   7.917	   46	   .172	   	   	  Total	   8.500	   49	   	   	   	  Overall	  Sleep	  Quality	   Between	  Groups	   1.321	   3	   .440	   .613	   .610	  Within	  Groups	   32.312	   45	   .718	   	   	  Total	   33.633	   48	   	   	   	  Need	  Meds	  to	  Sleep	   Between	  Groups	   1.271	   3	   .424	   .272	   .845	  Within	  Groups	   70.076	   45	   1.557	   	   	  Total	   71.347	   48	   	   	   	  Total	   Between	  Groups	   9.046	   3	   3.015	   .221	   .881	  Within	  Groups	   627.454	   46	   13.640	   	   	  Total	   636.500	   49	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Table	  7:	  
ESASr	  and	  Age	  Descriptives	  	  	   	  	   N	   Mean	   Standard	  Deviation	  Total	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  19-­‐40	  41-­‐50	  51-­‐60	  61-­‐72	  Total	  
10	  11	  12	  15	  48	  
18.59	  19.66	  23.71	  21.21	  20.93	  
8.812	  12.526	  12.736	  12.505	  11.677	  Pain	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  19-­‐40	  41-­‐50	  51-­‐60	  61-­‐72	  Total	  
10	  11	  12	  15	  48	  
2.80	  2.09	  3.29	  1.81	  2.45	  
1.307	  2.311	  2.744	  1.569	  2.079	  Tiredness	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  19-­‐40	  	  41-­‐50	  51-­‐60	  61-­‐72	  Total	  
10	  11	  12	  15	  48	  
3.53	  3.62	  4.13	  3.81	  3.79	  
1.171	  1.882	  1.521	  2.207	  1.749	  Drowsiness	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  19-­‐40	  41-­‐50	  51-­‐60	  61-­‐72	  Total	  
10	  11	  12	  15	  48	  
2.94	  2.85	  3.25	  2.88	  2.98	  
1.644	  1.900	  1.776	  2.132	  1.845	  Nausea	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  19-­‐40	  41-­‐50	  51-­‐60	  61-­‐72	  Total	  
10	  11	  12	  15	  48	  
1.29	  1.57	  1.74	  1.81	  1.63	  
1.641	  1.916	  1.714	  2.405	  1.936	  Lack	  of	  Appetite	  	  	  	  	  	  	  	  	  	  	  	  19-­‐40	  41-­‐50	  51-­‐60	  61-­‐72	  Total	  
10	  11	  12	  15	  48	  
3.00	  3.65	  3.08	  4.60	  3.67	  
2.539	  2.964	  2.718	  2.261	  2.611	  Shortness	  of	  Breath	  	  	  	  	  	  19-­‐40	  41-­‐50	  51-­‐60	  61-­‐72	  Total	  
10	  11	  12	  15	  48	  
1.39	  .82	  1.05	  1.53	  1.22	  
1.662	  1.510	  1.140	  1.994	  1.608	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  Depression	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  19-­‐40	  41-­‐50	  51-­‐60	  61-­‐72	  Total	  
10	  11	  12	  15	  48	  
.53	  .99	  1.93	  1.36	  1.24	  
.876	  1.923	  1.750	  1.569	  1.622	  Anxiety	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  19-­‐40	  41-­‐50	  51-­‐60	  61-­‐72	  Total	  
10	  11	  12	  15	  48	  
.81	  1.06	  2.31	  1.55	  1.48	  
.878	  1.733	  2.291	  1.583	  1.753	  Wellbeing	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  19-­‐40	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  41-­‐50	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  51-­‐60	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  61-­‐72	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Total	  
1011121548	  
2.30	  3.04	  2.74	  2.50	  2.64	  









Squares	   df	  
Mean	  
Square	   F	   Sig.	  Total	   Between	  Groups	   166.820	   3	   55.607	   .392	   .759	  Within	  Groups	   6241.505	   44	   141.852	   	   	  Total	   6408.325	   47	   	   	   	  Pain	   	   Between	  Groups	   17.075	   3	   5.692	   1.346	   .272	  Within	  Groups	   186.057	   44	   4.229	   	   	  Total	   203.132	   47	   	   	   	  Tiredness	   Between	  Groups	   2.437	   3	   .812	   .253	   .859	  Within	  Groups	   141.403	   44	   3.214	   	   	  Total	   143.840	   47	   	   	   	  Drowsiness	   Between	  Groups	   1.219	   3	   .406	   .113	   .952	  Within	  Groups	   158.772	   44	   3.608	   	   	  Total	   159.992	   47	   	   	   	  Nausea	   Between	  Groups	   1.847	   3	   .616	   .155	   .926	  Within	  Groups	   174.231	   44	   3.960	   	   	  Total	   176.078	   47	   	   	   	  Lack	  of	  Appetite	   Between	  Groups	   21.652	   3	   7.217	   1.063	   .374	  Within	  Groups	   298.684	   44	   6.788	   	   	  Total	   320.336	   47	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  Shortness	  of	  	  	  	  Breath	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Between	  Groups	  Within	  Groups	  Total	   3.876	  117.602	  121.478	   3	  44	  47	   1.292	  2.673	   .483	   .697	  Depression	   Between	  Groups	   11.659	   3	   3.886	   1.526	   .221	  	   Within	  Groups	   112.029	   44	   2.546	   	   	  	   	  Total	   123.688	   47	   	   	   	  Anxiety	  	  	  	  	  	  	  	  	  	  	  	  	  	  Between	  Groups	  Within	  Groups	  Total	   14.664	  129.788	  144.451	   3	  44	  47	  
4.888	  2.950	   1.657	   .190	  
Wellbeing	  	  	  	  	  	  	  	  	  Between	  Groups	  Within	  Groups	  Total	   3.310	  150.015	  153.325	   3	  44	  47	  
1.103	  3.409	   .324	   .808	  
.	  
Table	  9:	  	  
PSQI	  and	  Scent	  Descriptives	   	  	  
	   Scent	   N	   Mean	  
Standard	  
Deviation	  Duration	  of	  Sleep	   C	  L	  P	  Total	  
7	  29	  14	  50	  
.57	  1.31	  1.57	  1.28	  
.535	  1.257	  1.089	  1.161	  Sleep	  Latency	  	   C	  L	  P	  Total	  
7	  29	  14	  50	  
.57	  1.17	  1.14	  1.08	  
.535	  .966	  .864	  .900	  Day	  Dysfunction	  due	  to	  Sleepiness	  
C	  L	  P	  Total	  
7	  29	  14	  50	  
.00	  .48	  .71	  .48	  
.000	  .574	  .726	  .614	  
Sleep	  Efficiency	   C	  L	  P	  Total	  
7	  29	  14	  50	  
3.00	  2.86	  2.93	  2.90	  
.000	  .516	  .267	  .416	  Overall	  Sleep	  Quality	  	  
C	  L	  P	  Total	  
7	  29	  13	  49	  
1.00	  1.31	  1.77	  1.39	  
.577	  .850	  .832	  .837	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Need	  Meds	  to	  Sleep	   C	  L	  P	  Total	  
7	  29	  13	  49	  
1.14	  1.24	  1.08	  1.18	  
1.464	  1.185	  1.256	  1.219	  Total	  	   C	  L	  P	  Total	  
7	  29	  14	  50	  
7.57	  9.72	  10.71	  9.70	  
1.397	  3.683	  3.911	  3.604	  	  	  
Table	  10:	  	  
PSQI	  and	  Scent	  	  	   Sum	  of	  Squares	   df	   Mean	  Square	   F	   Sig.	  Duration	  of	  Sleep	   Between	  Groups	   4.730	   2	   2.365	   1.812	   .175	  Within	  Groups	   61.350	   47	   1.305	   	   	  Total	   66.080	   49	   	   	   	  Sleep	  Latency	   Between	  Groups	   2.113	   2	   1.057	   1.322	   .276	  Within	  Groups	   37.567	   47	   .799	   	   	  Total	   39.680	   49	   	   	   	  Day	  Dysfunction	  due	  to	  Sleepiness	  
Between	  Groups	   2.381	   2	   1.191	   3.476	   .039	  	  Within	  Groups	   16.099	   47	   .343	   	   	  Total	   18.480	   49	   	   	   	  Sleep	  Efficiency	   Between	  Groups	   .123	   2	   .062	   .345	   .710	  Within	  Groups	   8.377	   47	   .178	   	   	  Total	   8.500	   49	   	   	   	  Overall	  Sleep	  Quality	   Between	  Groups	   3.118	   2	   1.559	   2.350	   .107	  Within	  Groups	   30.515	   46	   .663	   	   	  Total	   33.633	   48	   	   	   	  Need	  Meds	  to	  Sleep	   Between	  Groups	   .256	   2	   .128	   .083	   .921	  Within	  Groups	   71.091	   46	   1.545	   	   	  Total	   71.347	   48	   	   	   	  Total	   Between	  Groups	   46.135	   2	   23.068	   1.836	   .171	  Within	  Groups	   590.365	   47	   12.561	   	   	  Total	   636.500	   49	   	   	   	  	   	  	  	  	  
AROMATHERAPY	  EFFECTS	  ON	  GENDER,	  AGE,	  AND	  SCENT	   	  	   32	  
Table	  11:	  
ESASr	  and	  Scent	  Descriptives	  	  	   	   N	   Mean	   Standard	  Deviation	  Total	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  C	  L	  P	  Total	  
7	  27	  14	  48	  
22.98	  19.33	  23.00	  20.93	  
14.238	  12.293	  9.217	  11.677	  Pain	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  C	  L	  P	  Total	  
7	  27	  14	  48	  
1.91	  2.67	  2.30	  2.45	  
1.858	  2.373	  1.580	  2.079	  Tiredness	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  C	  L	  P	  Total	  
7	  27	  14	  48	  
3.26	  3.68	  4.27	  3.79	  
1.273	  1.906	  1.619	  1.749	  Drowsiness	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  C	  L	  P	  Total	  
7	  27	  14	  48	  
3.08	  2.92	  3.04	  2.98	  
1.433	  1.934	  1.965	  1.845	  Nausea	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  C	  L	  P	  Total	  
7	  27	  14	  48	  
2.43	  1.38	  1.71	  1.63	  
2.167	  2.013	  1.669	  1.936	  Lack	  of	  Appetite	  	  	  	  	  	  	  	  	  	  	  	  	  C	  L	  P	  Total	  
7	  27	  14	  48	  
3.98	  2.94	  4.92	  3.67	  
2.501	  2.461	  2.608	  2.611	  Shortness	  of	  Breath	  	  	  	  	  	  C	  L	  P	  Total	  
7	  27	  14	  48	  
1.35	  1.06	  1.46	  1.22	  
1.726	  1.517	  1.800	  1.608	  Depression	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  C	  L	  P	  Total	  
7	  27	  14	  48	  
1.78	  1.22	  1.02	  1.24	  
1.861	  1.814	  1.061	  1.622	  Anxiety	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  C	  L	  P	  Total	  
7	  27	  14	  48	  
2.00	  1.38	  1.41	  1.48	  
2.024	  1.802	  1.598	  1.753	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  Wellbeing	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  C	  L	  P	  Total	  
7	  27	  14	  48	  
2.88	  2.07	  3.62	  2.64	  
1.830	  1.636	  1.775	  1.806	  	  	  	  
Table	  12:	  
ESASr	  and	  Scent	  	   	  	   Sum	  of	  
Squares	  
df	   Mean	  
Square	  
F	   Sig.	  Total	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Between	  Groups	  Within	  Groups	  Total	   158.212	  6250.113	  6408.325	   2	  45	  47	   79.106	  138.891	   .570	   .570	  Pain	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Between	  Groups	  Within	  Groups	  Total	   3.599	  199.533	  203.132	   2	  45	  47	   1.799	  4.434	   .406	   .669	  Tiredness	  	  	  	  	  	  	  	  	  Between	  Groups	  Within	  Groups	  Total	   5.542	  138.298	  143.840	   2	  45	  47	   2.771	  3.073	   .902	   .413	  Drowsiness	  	  	  	  	  	  Between	  Groups	  Within	  Groups	  Total	   .211	  159.781	  159.992	   2	  45	  47	   .105	  3.551	   .030	   .971	  Nausea	  	  	  	  	  	  	  	  	  	  	  	  	  	  Between	  Groups	  Within	  Groups	  Total	   6.309	  169.769	  176.078	   2	  45	  47	   3.155	  3.773	   .836	   .440	  Lack	  of	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Between	  Groups	  Appetite	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Within	  Groups	  Total	   36.872	  283.464	  320.336	   2	  45	  47	   18.436	  6.299	   2.927	   .064	  Shortness	  	  	  	  	  	  	  	  	  Between	  Groups	  of	  Breath	  	  	  	  	  	  	  	  	  	  	  	  	  	  Within	  Groups	  Total	   1.619	  119.859	  121.478	   2	  45	  47	   .809	  2.664	   .304	   .739	  Depression	  	  	  	  	  	  Between	  Groups	  Within	  Groups	  Total	   2.717	  120.971	  123.688	   2	  45	  47	   1.359	  2.688	   .505	   .607	  Anxiety	  	  	  	  	  	  	  	  	  	  	  	  	  	  Between	  Groups	  Within	  Groups	  Total	   2.263	  142.188	  144.451	   2	  45	  47	   1.131	  3.160	   .358	   .701	  Wellbeing	  	  	  	  	  	  	  	  	  Between	  Groups	  Within	  Groups	  Total	   22.693	  130.632	  153.325	   2	  45	  47	   11.347	  2.903	   3.909	   .027	  
 
